Litcius/Paper detail

Late effects after high-risk neuroblastoma (LEAHRN): a multicentre, cross-sectional cohort study from the Children's Oncology Group

Tara O. Henderson, Jenna K. Bardwell, Pei-Chi Kao, Paul C. Nathan, Wendy Landier, Sogol Mostoufi‐Moab, Tara M. Brinkman, Fiona Schulte, Julie R. Park, Saro H. Armenian, Arlene Naranjo, Meera Subramaniam, Araz Marachellian, Sharon J. Diskin, Wendy B. London, Lisa Diller

2025The Lancet Child & Adolescent Health8 citationsDOIOpen Access PDF

Topics & Concepts

MedicineOncologyInternal medicineClinical OncologyNeuroblastomaClinical trialCohort studyCancerCohortPediatric oncologyMEDLINEResearch designEpidemiology of cancerChemotherapyRetrospective cohort studyNeuroblastoma Research and TreatmentsLung Cancer Research StudiesCancer therapeutics and mechanisms
Late effects after high-risk neuroblastoma (LEAHRN): a multicentre, cross-sectional cohort study from the Children's Oncology Group | Litcius